- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Canadian C-spine Rule Best for Spine Injury Screening
Canadian C-spine rule is more accurate in screening for cervical spine injury compared with NEXUS, but more education is needed to curb imaging.
The Canadian C-spine rule results in better diagnostic accuracy in screening for cervical spine injury following blunt trauma compared with the National Emergency X-Radiography Utilization Study (NEXUS) criteria, according to a study published in the October issue of the Canadian Medical Association Journal.
Both rules are used internationally, but there is no consensus as to which rule is preferable. Researchers from Australia and the Netherlands searched the literature for studies to see if one rule was more effective. Fifteen studies matched their criteria, however, only study directly compared the accuracy of the two rules. The results showed that the Canadian C-spine rule had better accuracy. The other studies evaluated one or the other.
The researchers found that sensitivity ranged from 90 percent to 100 percent with specificity of 1 percent to 77 percent with the Canadian rule. For NEXUS, sensitivity ranged from 83 percent to 100 percent with specificity of 2 percent to 46 percent.
“We found that the Canadian C-spine rule appears to have better diagnostic accuracy than the NEXUS criteria,” the authors wrote.
However, clinical practices are relying on a more liberal use of imaging, which may be because of patient preference, malpractice fears or uncertainty of the accuracy of the screening tools, the authors said. “Improved education of physicians may facilitate greater use of these rules."
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
